Company / Cash & Equivalents
Privia Health Group, Inc. Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$479.7M
FY2025
5-year range
$320.6M / $491.1M
FY2021-FY2025
Trend
-2.3%
vs FY2024
Sector context
#50 of 148
Health Care
What the data says
At $480M, Privia Health Group, Inc.'s cash & equivalents ranks #50 of 148 in the Health Care sector. Improved from $390M to $480M over the past 2 years.
Based on SEC 10-K filings.
$480M in FY2025 with a 5-year CAGR of +41.5%.
Improved from $390M to $480M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +11.3%
- 5-Year CAGR
- +41.5%
- 10-Year CAGR
- -
Sector benchmark
#50 of 148 in Health CareTop 34% of 148This company $479.7M Sector average $1.2B
▼
-59.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +41.5%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 2.3% year-over-year.
- Ranks #50 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $479.7M | -2.3% |
| FY2024 | $491.1M | +26.1% |
| FY2023 | $389.5M | +11.9% |
| FY2022 | $348.0M | +8.6% |
| FY2021 | $320.6M | +278.8% |
| FY2020 | $84.6M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026